Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05764824 · ClinicalTrials.gov registry record · NA
Long-term Effects of Blueberry Supplementation on Brain Health in Older Adults
A NA study of Cognitive Decline and Nutrition, Healthy, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT05764824: Completed NA study of Cognitive Decline and Nutrition, Healthy, sponsored by Brigham and Women's Hospital.
NCT05764824 is a NA study of Cognitive Decline and Nutrition, Healthy that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 67 participants, below the 1,148-participant average among 61 other Cognitive Decline trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05764824, a NA study of Cognitive Decline and Nutrition, Healthy, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test whether consuming blueberry powder 20g/d for 24 weeks can improve memory and other cognitive function and alter serum biomarkers of brain injury among older adults.
Primary Outcome
Change will be calculated as difference between plasma NFL concentration measured at 24 weeks and NFL concentration measured at baseline.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Blueberry powder
- OTHER Controlled and matched powder
Study Locations (1)
Massachusetts
- Mass General Brigham - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2024-09-11 |
| Phase | NA |
What the finished NCT05764824 record still lists
NCT05764824 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 1,148-participant average among 61 other Cognitive Decline trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Cognitive Decline appearing as the primary indexed condition, and to 2 interventions - of which Blueberry powder is the first listed.
NCT05764824 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05764824 about?
NCT05764824 is a clinical study titled "Long-term Effects of Blueberry Supplementation on Brain Health in Older Adults". This study will test whether consuming blueberry powder 20g/d for 24 weeks can improve memory and other cognitive function and alter serum biomarkers of brain injury among older adults.
What is the current status of trial NCT05764824?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2023-10-01. Estimated completion is 2024-09-11.
What conditions does trial NCT05764824 study?
This clinical trial studies the following conditions: Cognitive Decline, Nutrition, Healthy, Brain Injuries.
What interventions are being tested in trial NCT05764824?
The interventions under investigation include: Blueberry powder (DIETARY_SUPPLEMENT), Controlled and matched powder (OTHER).
Who is sponsoring clinical trial NCT05764824?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05764824 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Decline
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05764824's enrollment target sits among peer trials
67 48th of 61 higher than 14 of 61 other Cognitive Decline trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Decline trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
MindWalk Intervention for Older South Asian Caregivers of People With Cognitive Disabilities (CD)
RECRUITING · NA
-
Preventing Cognitive Decline by Reducing BP Target Trial
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
-
Exercise Adherence and Cognitive Decline: Phase 2
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI